RAFAGEN’s primary focus is the development and commercialization of next generation gene expression systems with applications in solving the most challenging problems in molecular therapeutics. RAFAGEN will leverage its core technology to build up a strategic framework for revenue generation in lice…
RAFAGEN’s primary focus is the development and commercialization of next generation gene expression systems with applications in solving the most challenging problems in molecular therapeutics. RAFAGEN will leverage its core technology to build up a strategic framework for revenue generation in licensing deals and service contracts, and eventually, for its own development of highly effective molecular therapy drugs.
Team (1)
Sectors Rafagen serves:
Life Sciences
Join Axial's Private M&A Platform
Rafagen connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
